SK Biopharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
SK Biopharmaceuticals does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 0.03% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
SK Biopharmaceuticals Co., Ltd. (KRX:326030) Shares Could Be 47% Below Their Intrinsic Value Estimate
Nov 27
There May Be Underlying Issues With The Quality Of SK Biopharmaceuticals' (KRX:326030) Earnings
Aug 22SK Biopharmaceuticals Co., Ltd. (KRX:326030) Looks Just Right With A 25% Price Jump
Aug 21Does This Valuation Of SK Biopharmaceuticals Co., Ltd. (KRX:326030) Imply Investors Are Overpaying?
May 22SK Biopharmaceuticals Co., Ltd. (KRX:326030) Not Lagging Industry On Growth Or Pricing
Apr 09Is SK Biopharmaceuticals (KRX:326030) A Risky Investment?
Feb 27We're Not Worried About SK Biopharmaceuticals' (KRX:326030) Cash Burn
Mar 12Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A326030's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A326030's dividend payments have been increasing.
Dividend Yield vs Market
| SK Biopharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A326030) | n/a |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 3.9% |
| Industry Average (Pharmaceuticals) | 1.1% |
| Analyst forecast (A326030) (up to 3 years) | 0.03% |
Notable Dividend: Unable to evaluate A326030's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A326030's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate A326030's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A326030 has not reported any payouts.